A detailed history of Silicon Valley Capital Partners transactions in Haleon PLC stock. As of the latest transaction made, Silicon Valley Capital Partners holds 95 shares of HLN stock, worth $871. This represents 0.0% of its overall portfolio holdings.

Number of Shares
95
Holding current value
$871
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Sep 11, 2025

BUY
$9.27 - $11.41 $880 - $1,083
95 New
95 $0

Others Institutions Holding HLN

About Haleon plc


  • Ticker HLN
  • Exchange
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 4,617,290,240
  • Market Cap $42.3B
  • Description
  • Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, mineral...
More about HLN
Track This Portfolio

Track Silicon Valley Capital Partners Portfolio

Follow Silicon Valley Capital Partners and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Silicon Valley Capital Partners, based on Form 13F filings with the SEC.

News

Stay updated on Silicon Valley Capital Partners with notifications on news.